Sws Partners Mei Pharma, Inc. Transaction History

Sws Partners

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 15, 2018	SELL	$2.06 - $2.38 $2,060 - $2,380	-1,000 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$1.91 - $2.83 $1,910 - $2,830	1,000	1,000 $2,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $366M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Sws Partners, based on Form 13F filings with the SEC.

Stay updated on Sws Partners with notifications on news.